11-86408205-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001156474.2(CCDC81):āc.1048G>Cā(p.Glu350Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,613,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001156474.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC81 | NM_001156474.2 | c.1048G>C | p.Glu350Gln | missense_variant | 9/15 | ENST00000445632.7 | NP_001149946.1 | |
CCDC81 | NM_021827.5 | c.778G>C | p.Glu260Gln | missense_variant | 8/14 | NP_068599.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC81 | ENST00000445632.7 | c.1048G>C | p.Glu350Gln | missense_variant | 9/15 | 1 | NM_001156474.2 | ENSP00000415528.2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000836 AC: 21AN: 251146Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135746
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461742Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727176
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2024 | The c.1048G>C (p.E350Q) alteration is located in exon 9 (coding exon 9) of the CCDC81 gene. This alteration results from a G to C substitution at nucleotide position 1048, causing the glutamic acid (E) at amino acid position 350 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at